vTv Therapeutics (VTVT) Gains from Investment Securities (2014 - 2025)
vTv Therapeutics' (VTVT) quarterly Gains from Investment Securities came in at $152000.0 in Q4 2025, up 72.73% year-on-year from $88000.0 in Q4 2024, and up 200.0% quarter-over-quarter from -$152000.0 in Q3 2025.
vTv Therapeutics (VTVT) Gains from Investment Securities (2014 - 2025) Analysis & Trends
vTv Therapeutics has disclosed Gains from Investment Securities across 12 years of filings, most recently posting $152000.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $152000.0, up 72.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $84000.0 (up 1780.0% YoY), and the FY2025 annual result was $51000.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $152000.0 for Q4 2025 at vTv Therapeutics, up from -$152000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.1 million in Q4 2021 to a low of -$152000.0 in Q3 2025.
- The 5-year median for Gains from Investment Securities is $86000.0 (2024), against an average of $1.2 million.
- Across the five-year window, Gains from Investment Securities surged 25910.95% in 2021 and plunged 102.07% in 2024, its largest moves.
- vTv Therapeutics' Gains from Investment Securities stood at $7.1 million in 2021, then tumbled by 97.17% to $200000.0 in 2022, then jumped by 2022.5% to $4.2 million in 2023, then sank by 97.93% to $88000.0 in 2024, then jumped by 72.73% to $152000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $152000.0 (Q4 2025), -$152000.0 (Q3 2025), and $84000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152,000.00 |
| Dec 31, 2025 | 152,000.00 |
| Sep 30, 2025 | -152,000.00 |
| Sep 30, 2025 | -152,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Mar 31, 2025 | -33,000.00 |
| Mar 31, 2025 | -33,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Sep 30, 2023 | 4.25 Mn |
| Sep 30, 2023 | 4.25 Mn |
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |